Table 1.
Clinicopathologic characteristics of the study cohort stratified by WBC
| Parameters | Total (n = 286) | WBC ≤11 000 (n = 252) | WBC >11 000 (n = 34) | p values |
|---|---|---|---|---|
| N | 286 | 252 | 34 | |
| Age | ||||
| <70 | 240 (83.9%) | 212 (84.1%) | 28 (82.4%) | 0.792 |
| ≥70 | 46 (16.1%) | 40 (15.9%) | 6 (17.6%) | |
| Gender | ||||
| Male | 256 (89.5%) | 225 (89.3%) | 31 (91.2%) | 1.000 |
| Female | 30 (10.5%) | 27 (10.7%) | 3 (8.8%) | |
| Lymph node invasion | ||||
| Negative | 244 (85.3%) | 215 (85.3%) | 29 (85.3%) | 1.000 |
| Positive | 42 (14.7%) | 37 (14.7%) | 5 (14.7%) | |
| Tumour stage | ||||
| T0 | 32 (11.2%) | 32 (12.7%) | 0 (0%) | 0.048 |
| T1 | 49 (17.1%) | 44 (17.5%) | 5 (14.6%) | |
| T2 | 81 (28.3%) | 70 (27.8%) | 11 (32.4%) | |
| T3 | 73 (25.5%) | 66 (26.2%) | 7 (20.6%) | |
| T4 | 51 (17.8%) | 40 (15.8%) | 11 (32.4%) | |
| Histological type | ||||
| Urothelial carcinoma | 236 (82.5%) | 209 (82.9%) | 27 (79.4%) | 0.611 |
| Non-urothelial carcinoma | 50 (17.5%) | 43 (17.1%) | 7 (20.6%) | |
| Surgical margin | ||||
| Positive | 18 (6.3%) | 14 (5.6%) | 4 (9.4%) | 0.247 |
| Negative | 268 (93.7%) | 238 (94.4%) | 30 (90.6%) | |
| Grade | ||||
| 3 | 190 (66.4%) | 160 (63.4%) | 30 (83.3%) | 0.004; |
| ≤2 | 96 (33.6%) | 92 (36.6%) | 4 (6.7%) | |
| Lymphovascular invasion | ||||
| Positive | 51 (17.8%) | 39 (15.5%) | 12 (35.3%) | 0.005 |
| Negative | 235 (82.2%) | 213 (84.5%) | 22 (64.7%) | |
| Carcinoma in-situ | ||||
| Positive | 19 (6.6%) | 17 (6.7%) | 2 (5.9%) | 1.000 |
| Negative | 267 (93.4%) | 235 (93.3%) | 32 (94.1%) | |
| Preoperative hydronephrosis | ||||
| Positive | 66 (23.1%) | 56 (22.2%) | 10 (29.4%) | 0.350 |
| Negative | 220 (76.9%) | 196 (77.8%) | 24 (70.6%) |
WBC: white blood cell count.